Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.

http://www.wikidata.org/entity/Q35094556

about

Interleukin-1beta enhances nucleotide-induced and alpha-secretase-dependent amyloid precursor protein processing in rat primary cortical neurons via up-regulation of the P2Y(2) receptor Secreted phospholipase A2 involvement in neurodegeneration: differential testing of prosurvival and anti-inflammatory effects of enzyme inhibition Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models Cross-talk between oxysterols and glucocorticoids: differential regulation of secreted phopholipase A2 and impact on oligodendrocyte death Gene expression profiling in cells with enhanced gamma-secretase activity.A secretory phospholipase A2-mediated neuroprotection and anti-apoptosis.Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.Secretory phospholipase A2 type III enhances alpha-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidity.Coordination of gene expression of arachidonic and docosahexaenoic acid cascade enzymes during human brain development and aging.Neuroinflammation and neurodegeneration in adult rat brain from binge ethanol exposure: abrogation by docosahexaenoic acid.Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability.Coordinated gene expression of neuroinflammatory and cell signaling markers in dorsolateral prefrontal cortex during human brain development and aging.Choline-containing phospholipids in microdissected human Alzheimer's disease brain senile plaque versus neuropil.Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex.Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA₂-IIA expression in astrocytes and microglia.TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat.Astrocytes regulate α-secretase-cleaved soluble amyloid precursor protein secretion in neuronal cells: Involvement of group IIA secretory phospholipase A2 Global changes of phospholipids identified by MALDI imaging mass spectrometry in a mouse model of Alzheimer's disease.Alcohol, phospholipase A2-associated neuroinflammation, and ω3 docosahexaenoic acid protection.Low-dose aspirin (acetylsalicylate) prevents increases in brain PGE2, 15-epi-lipoxin A4 and 8-isoprostane concentrations in 9 month-old HIV-1 transgenic rats, a model for HIV-1 associated neurocognitive disorders.A dangerous liaison: Leptin and sPLA2-IIA join forces to induce proliferation and migration of astrocytoma cells Role of Lipids in Brain Injury and Diseases.Altered lipid metabolism in brain injury and disorders.Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies.Neuroprotective effects of a nanocrystal formulation of sPLA(2) inhibitor PX-18 in cerebral ischemia/reperfusion in gerbils Involvement of oxidative pathways in cytokine-induced secretory phospholipase A2-IIA in astrocytes.Phospholipases A2 and inflammatory responses in the central nervous system.Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease.Macrophage migration inhibitory factor activates inflammatory responses of astrocytes through interaction with CD74 receptor.Positive and negative effects of prostaglandins in Alzheimer's disease.The role of secretory phospholipase A₂ in the central nervous system and neurological diseases.Proteome of brain glia: the molecular basis of diverse glial phenotypes.Cellular membrane fluidity in amyloid precursor protein processing.Structure of N-terminal sequence Asp-Ala-Glu-Phe-Arg-His-Asp-Ser of Aβ-peptide with phospholipase A2 from venom of Andaman Cobra sub-species Naja naja sagittifera at 2.0 Å resolution.The proteome of the differentiating mesencephalic progenitor cell line CSM14.1 in vitro.Physiological and Pathological Roles of 15-Deoxy-Δ12,14-Prostaglandin J2 in the Central Nervous System and Neurological Diseases.Kainate receptors mediate regulated exocytosis of secretory phospholipase A(2) in SH-SY5Y neuroblastoma cells.

P2860

Q28574838-7B8868CD-3934-413F-96BE-0C14D2D14D81 Q28728398-B988893D-D655-4DD3-8E1F-CD47DFAE5725 Q30499792-CD2102B7-E447-4FB2-8A5C-99C672B9A6D5 Q30943736-0A5ECA40-4588-4D2B-A1F2-239718DADF2B Q33504576-70B36FD0-C1A5-47EF-AE72-6B2248859168 Q33506180-2CEA6A5C-8637-4A66-BDEA-BBA3E054A213 Q33565825-DE25068C-E7B4-451E-A1A8-3202A24AEF46 Q33712475-BCC91DB8-A7FA-4A94-9FBA-0EF6444F1C67 Q33784636-80849A4C-D142-4BD0-9381-0FE5BA395723 Q33806815-403A58C8-627A-4A73-9E08-00DF89CE380D Q33910127-938B3431-E1EA-480B-9598-C9ADE645BBDE Q33912628-877CAC0B-4B2D-4395-A381-79F343E62F88 Q34374526-E7C40E75-4C4B-4DE4-A2E7-DA5CB12C1C45 Q34421898-55FC89C8-4ABE-4532-ACD5-B9A3316B49D5 Q34679377-D3DE2678-2B04-4588-971C-C9DA2F19D495 Q35218379-12A6BF36-CCE6-4F62-A167-88CD017854EC Q35505146-AD2ED4EC-F74B-415B-9BE4-5CBA199668CC Q35593790-6BFA84D0-21CB-449B-9CEF-4A6F23F44A33 Q35757950-B6B08A26-AC02-4BEA-93FD-5C84D72141A9 Q35798170-F5E9C49F-45C1-4F4E-910B-4D9CCDEBCC2D Q35833029-75C85BD2-2EB6-406D-A7AB-76C60767991F Q35879838-7487B502-0800-4810-8500-BBB6351EA98A Q36035835-8F4E32BE-968E-4ECD-82CB-D7DE1F4FFAFA Q36294159-70109A29-1C39-4B49-99DF-0F314424AFE5 Q37051065-3D46BCD3-BD68-4B6A-9FE0-7A170697FCCF Q37254313-C8DAC370-E01B-46E5-9BEA-3F46225DF142 Q37255394-FD244241-5C38-48A3-BF38-28FC9439F698 Q37343248-C5858170-19A0-4EA5-BD06-6BEEC6800553 Q37401591-8EC2015D-3CE1-4C6D-AE6B-1017081D0862 Q37621283-CD628DEE-E181-43FB-B520-92F95708442A Q37701322-361150B3-A57E-4F01-947B-BEC26FADF1BC Q37709362-54092EBA-D92C-449D-97DF-ACE77BB578EE Q38132922-805C9587-6B4B-4DC2-8430-1B3B5AC01E86 Q38151471-66932285-429B-47F8-9A5B-32CB2AE7D2C5 Q38152439-EA221E0C-3194-4CBC-92D2-4A93C53C3B80 Q38189670-3CD4C1D0-7F68-4F5C-B255-D13F17EB8022 Q38612518-4427664B-E05C-4DBE-944B-305596344428 Q39018803-CC9F1BCE-1828-4E5B-825A-1EB995CDCD58 Q39181325-73FB2D92-0224-4879-AD84-B8C0EDEEE955 Q39453331-E85842CD-BCD5-42B3-A10A-BE0AD0C53E73

P2860

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.

http://www.wikidata.org/entity/Q35094556

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.

@ast

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.

@en

type

label

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.

@ast

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.

@en

prefLabel

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.

@ast

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.

@en

P1433

Q35094556-3852F14B-AC7C-4EEA-A170-5723F758C4E1

P1476

Q35094556-BE3120EC-BF32-4C1E-8583-6BF02B35F0E7

P2093

Q35094556-1E2844D9-82AB-4CCE-8927-FC020CA5E203

Q35094556-20C3E37C-0038-4E86-A639-43BB09FC2E91

Q35094556-4CC920A5-F83B-4EF3-A69B-FA4B3D4DDA43

Q35094556-57D01575-B8D2-4DC8-AC8A-FDCA8DBF9529

Q35094556-96EE97F2-8896-4F4E-BD65-B5B07B7D3921

Q35094556-DB95C5AF-CB98-4957-B693-AC08BA1ADBE6

Q35094556-F9897A2D-3A0A-43E4-9035-CCE872AFB13F

P2860

Q35094556-033117B6-2578-4353-9530-0BAAEB1BBC06

Q35094556-05AAF694-EB5B-403F-A01B-47D9F4BA4584

Q35094556-06265708-DC94-447A-80C0-26D872CC88E3

Q35094556-146F51AC-27F1-413E-A4A8-655A66A7E8C6

Q35094556-19EEB738-4F85-40CB-B523-9BEAD044C42F

Q35094556-1ED36ED1-578C-4C97-82AD-B13447D9641C

Q35094556-23387CFD-F7DF-4EA7-A335-4E41E71D2B9B

Q35094556-2802F347-BC7E-4ADD-B752-31A53BB19565

Q35094556-2D203D1C-999C-4F73-9A3D-E574C60108B3

Q35094556-4181F0D6-3CCB-4FA4-A4D4-427B309C6424

P2888

Q35094556-09FF9907-3B55-4743-AF20-969AF27A9108

P304

Q35094556-7539B2EE-1C67-4D3F-B948-63283CBC7465

P31

Q35094556-3A736C57-B996-41CA-85C4-F274CEBA597A

P356

Q35094556-3F918613-09EE-4407-BF45-2622950AA651

P478

Q35094556-D931EA0F-5D52-433D-9856-127865F4DEB9

P577

Q35094556-5E953C25-F13F-4355-ADAA-DC5A3D398120

P5875

Q35094556-180A2F8A-8D5C-49A1-B07E-71E74C7064A5

P6179

Q35094556-16AAF7D4-9EC3-476D-9E32-23FF85B1AEC4

P698

Q35094556-E2DBA8AE-A8A5-495C-BDCE-AC2E99B7466A

P921

Q35094556-1353D3DA-7A73-4E83-8791-5A06E6A9F9EB

Q35094556-AA42DC2A-047E-4EB1-BD82-295ED1EFA63E

P932

Q35094556-C93054F7-10F9-44BC-A981-71A99B5DB402

P356

P1433

Journal of Neuroinflammation

P1476

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.

@en

P2093

Agnes Simonyi

http://www.w3.org/2001/XMLSchema#string

Albert Y Sun

http://www.w3.org/2001/XMLSchema#string

Douglas G Walker

http://www.w3.org/2001/XMLSchema#string

Grace Y Sun

http://www.w3.org/2001/XMLSchema#string

Guna S D Moses

http://www.w3.org/2001/XMLSchema#string

Lih-Fen Lue

http://www.w3.org/2001/XMLSchema#string

Michael D Jensen

http://www.w3.org/2001/XMLSchema#string

P2860

Secretory phospholipases A2 induce neurite outgrowth in PC12 cells through lysophosphatidylcholine generation and activation of G2A receptor

The interleukin-1 signalling pathway in astrocytes: a key contributor to inflammation in the brain

Inflammation and Alzheimer's disease

Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease

Rat brain cortex mitochondria release group II secretory phospholipase A(2) under reduced membrane potential.

Secretory phospholipase A2 activity in the normal and kainate injected rat brain, and inhibition by a peptide derived from python serum.

Role of nitric oxide in regulating secreted phospholipase A2 release from astrocytes.

Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins.

Phospholipase A(2) in vascular disease.

Glia and their cytokines in progression of neurodegeneration.

P2888

P304

28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-2094-3-28

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6767790

http://www.w3.org/2001/XMLSchema#string

P6179

1030549400

http://www.w3.org/2001/XMLSchema#string

P698

17026770

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1613236

http://www.w3.org/2001/XMLSchema#string